Correction: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy

• Jacqui T. Nimmo,
• Ajay Verma,
• Jean-Cosme Dodart,
• Chang Yi Wang,
• Jimmy Savistchenko,
• Ronald Melki,
• Roxana O. Carare,
• James A. R. Nicoll

Affiliations

Jacqui T. Nimmo

Clinical Neurosciences. Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton

Ajay Verma

United Neuroscience

Jean-Cosme Dodart

United Neuroscience

Chang Yi Wang

United Neuroscience

Jimmy Savistchenko

Institute Francois Jacob (MIRCen), CEA and Laboratory of Neurodegenerative Diseases, CNRS

Ronald Melki

Institute Francois Jacob (MIRCen), CEA and Laboratory of Neurodegenerative Diseases, CNRS

Roxana O. Carare

Clinical Neurosciences. Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton

James A. R. Nicoll

Clinical Neurosciences. Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton